...
首页> 外文期刊>Rheumatology International >Nickel-induced allergy and contact dermatitis: does it induce autoimmunity and cutaneous sclerosis? An experimental study in Brown Norway rats
【24h】

Nickel-induced allergy and contact dermatitis: does it induce autoimmunity and cutaneous sclerosis? An experimental study in Brown Norway rats

机译:镍诱发的过敏和接触性皮炎:它会诱发自身免疫和皮肤硬化吗?挪威褐鼠的实验研究

获取原文
获取原文并翻译 | 示例
           

摘要

Nickel sensitization is a growing problem and the most common cause of allergic contact dermatitis. The aim of this study was to investigate whether nickel chloride can induce autoimmunity and cutaneous sclerosis in immunosensitive rats. Nickel chloride, in a dose of 4.5 mg in 0.2 ml NS, was administered by the oral and subcutaneous routes to 20 Brown Norway rats. Autoantibodies (ANA, anti-RNP, anti-SCL70 and anti-centromere) were measured and compared in pre- and post-challenge serum samples. Histological studies were also performed in skin biopsies obtained from six positively responding rats and compared with an equal number of control rats at the 14th week post-challenge. Serum ANA was high in a significant number of rats in both the oral (P < 0.005) and subcutaneously nickel-treated groups (P = 0.02), while the anti-SCL70 was high in a significant number of rats in only the orally nickel-treated group (P = 0.04). Histologically, subcutaneous and oral nickel-treated groups showed sclerodermic features of the skin (P = 0.22, P = 0.5), respectively. It may be concluded that nickel chloride can induce scleroderma-related autoantibodies and cutaneous sclerosis. More prolonged duration of exposure is probably associated with greater risk. This is the first study showing the potential risk of nickel in triggering the development of cutaneous sclerosis in susceptible hosts.
机译:镍敏化是一个日益严重的问题,也是过敏性接触性皮炎的最常见原因。这项研究的目的是调查氯化镍是否可以在免疫敏感性大鼠中诱导自身免疫和皮肤硬化。通过口服和皮下途径向20只Brown Norwegian大鼠施用4.5毫克在0.2毫升NS中的氯化镍。在攻击前和攻击后血清样品中测量并比较自身抗体(ANA,抗RNP,抗SCL70和抗着丝粒)。还对从六只阳性反应大鼠中获得的皮肤活检组织进行了组织学研究,并在攻击后第14周与同等数量的对照大鼠进行了比较。口服(P <0.005)和镍皮下治疗组(P = 0.02)的大量大鼠血清ANA含量较高,而仅口服镍-镍治疗组的大量大鼠中的抗SCL70含量较高。治疗组(P = 0.04)。在组织学上,皮下和口服镍治疗组分别表现出皮肤的硬化特征(P = 0.22,P = 0.5)。可以得出结论,氯化镍可以诱导硬皮病相关的自身抗体和皮肤硬化。延长接触时间可能与更大的风险有关。这是第一项显示镍可能触发易感宿主发生皮肤硬化的潜在风险的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号